A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly

European Journal of Endocrinology

Volumn 159, Issue 2, 2008, Pages 89-95

  Holdaway, Ian M ^a   Bolland, M J ^b   Gamble, G D ^b  

^a GREEN LANE HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADJUVANT THERAPY; ARTICLE; BIOCHEMISTRY; CAUSE OF DEATH; CLINICAL TRIAL; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; REMISSION; SURVIVAL; SYSTEMATIC REVIEW; BLOOD; DOWN REGULATION; PHYSIOLOGY;

ACROMEGALY; CAUSE OF DEATH; DOWN-REGULATION; FOLLOW-UP STUDIES; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; REMISSION INDUCTION;

EID: 49649124901     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-08-0267     Document Type: Article

References (30)

1. Holdaway IM. Treatment of acromegaly. Hormone Research 2004 62 (Suppl 3) 79-92.
2. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA & Vandenbroucke JP. Mortality in acromegaly: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 2008 93 61-67.
3. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB & Wilson CB. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism 1998 83 3411-3418.
4. Alexander L, Appleton D, Hall R, Ross WM & Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clinical Endocrinology 1980 12 71-79.
5. Arita K, Kurisu K, Tominaga A, Eguchi K, Iida K, Uozumi T & Kasagi F. Mortality in 154 surgically treated patients with acromegaly - a 10-year follow-up survey. Endocrine Journal 2003 50 163-172.
6. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM & Bates AS, Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 1613-1617.
7. Bates AS, Van't Hoff W, Jones JM & Clayton RN. An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine 1993 86 293-299.
8. Beauregard C, Truong U, Hardy J & Serri O. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clinical Endocrinology 2003 58 86-91.
9. Bengtsson BA, Jonsson B & Nilsson B. Increased mortality in acromegaly is mainly caused by cardiovascular diseases, Abstracts of the 81st Annual Scientific Meeting US Endocrine Society 1999 P3-648.
10. Biermasz NR, Dekker FW, Pereira AM, van Thiel SW, Schutte PJ, van Dulken H, Romijn JA & Roelfsema F. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. Journal of Clinical Endocrinology and Metabolism 2004 89 2789-2796.
11. Etxabe J, Gaztambide S, Latorre P & Vazquez JA. Acromegaly: an epidemiological study. Journal of Endocrinological Investigation 1993 16 181-187.
12. Holdaway IM, Rajasoorya RC & Gamble GD. Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 667-674.
13. Kauppinen-Makelin R, Sane T, Reunanen A, Valimaki MJ, Niskanen L, Markkanen H, Loyttyniemi E, Ebeling T, Jaatinen P Laine H, Nuutila P, Salmela P, Salmi J, Stenman UH, Viikari J & Voutilainen E. A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2005 90 4081-4086.
14. Nabarro JD. Acromegaly. Clinical Endocrinology 1987 26 481-512.
15. Orme SM, McNally RJ, Cartwright RA & Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 1998 83 2730-2734.
16. Shimatsu A, Yokogoshi Y, Saito S, Shimizu N & Irie M. Long-term survival and cardiovascular complications in patients with acromegaly and pituitary gigantism. Journal of Endocrinological Investigation 1998 21 55-57.
17. Swearingen B, Barker FG II, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM & Zervas NT Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism 1998 83 3419-3426.
18. Trepp R, Stettler C, Zwahlen M, Seiler R, Diem P & Christ FR. Treatment outcomes and mortality of 94 patients with acromegaly Acta Neurochirurgica 2005 147 243-251 (discussion 250-241).
19. Wright AD, Hill DM, Lowy C & Fraser TR. Mortality in acromegaly. Quarterly Journal of Medicine 1970 39 1-16.
20. Bex M, Abs R, T'Sjoen G, Mockel J, Velkeniers B, Muermans K & Maiter D. AcroBel - the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. European Journal of Endocrinology 2007 157 399-409.
21. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ & Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology 1994 41 95-102.
22. Bengtsson BA, Eden S, Ernest I, Oden A & Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Medica Scandinavica 1988 223 327-335.
23. Ayuk J, Clayton RN, Sheppard MC, Stewart PM & Bates AS. Outcomes in acromegaly: a retrospective study of 419 patents from the West Midlands region of the United Kingdom, Abstracts of the 85th Annual Scientific Meeting US Endocrine Society 2003 126.
24. Armstrong BG. Comparing standardized mortality ratios. Annals of Epidemiology 1995 5 60-64.
25. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez IM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M & Gilabert M. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). European Journal of Endocrinology 2004 151 439-446.
26. Colao A, Ferone D, Marzullo P & Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 2004 25 102-152.
27. Schiavon F, Maffei P. Martini C, De Carlo E, Fais C, Tedesco S & Sicolo N. Morphologic study of microcirculation in acromegaly by capillaroscopy. Journal of Clinical Endocrinology and Metabolism 1999 84 3151-3155.
28. Brevetti G, MarzuIlo P, Silvestro A, Pivonello R, Oliva G, di Somma. C, Lombardi G & Colao A. Early vascular alterations in acromegaly. Journal of Clinical Endocrinology and Metabolism 2002 87 3174-3179.
29. Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D & Barreca A. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Clinical Endocrinology 2004 61 138-144.
30. Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE & Post KD. Significance of 'abnormal' nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. Journal of Clinical Endocrinology and Metabolism 2004 89 495-500.